Metraipolis › archive › dc_d643370a4253
Investigation of cyclic peptides as drug delivery systems for the delivery of the anti-tuberculosis drug pyrazinamide — Europe PMC PMID:42422351
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42422351
- DOI
- 10.1039/d5na01168j
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T09:17:38.453Z
- SHA-256 of the archived text
97786ae630b8c3390662d04ccf64ab52fb409c5d26ba65673ba0e52f657e9d88- Stable URL of this page
https://metraipolis.com/documento/dc_d643370a4253
How to cite
Investigation of cyclic peptides as drug delivery systems for the delivery of the anti-tuberculosis drug pyrazinamide — Europe PMC PMID:42422351 — Europe PMC (en), https://europepmc.org/article/MED/42422351 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d643370a4253 (Metraipolis archive dc_d643370a4253, sha256 97786ae630b8c3390662d04ccf64ab52fb409c5d26ba65673ba0e52f657e9d88)
BibTeX
@misc{dcd643370a4253,
title = {Investigation of cyclic peptides as drug delivery systems for the delivery of the anti-tuberculosis drug pyrazinamide — Europe PMC PMID:42422351},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42422351},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d643370a4253; sha256 97786ae630b8c3390662d04ccf64ab52fb409c5d26ba65673ba0e52f657e9d88},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42422351. Agents can read the archived copy with the MCP tool read_document.